Trade Summary

4 days ago, Goff Brian, serving as CEO at Agios Pharmaceuticals, Inc. (AGIO), sold 18,703 shares at $27.09 per share, for a total transaction value of $506,664.00. Following this transaction, Goff Brian now holds 143,103 shares of AGIO.

This sale represents a 12.00% decrease in Goff Brian's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, December 30, 2025 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, 3 days after the trade was made.

Agios Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.